Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Francis
D L
DL
Institute of Nuclear Medicine, University College of London, Middlesex Hospital, Mortimer Street, London, UK. daren.francis@ucl.ac.uk
Visvikis
D
D
Costa
D C
DC
Croasdale
I
I
Arulampalam
T H
TH
Luthra
S K
SK
Taylor
I
I
Ell
P J
PJ
D000970:Antineoplastic Agents / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D015224:Dideoxynucleosides; D019788:Fluorodeoxyglucose F18; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D009367:Neoplasm Staging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D015224:Dideoxynucleosides; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C002854:alovudine; D005472:Fluorouracil